Allopurinol	Control	Systolic blood pressure 	14169	14336	In first Phase, before and after dialysis, systolic BP were 134.6 and 122.1, which after treatment with allopurinol decreased to 119.8(P < 0.0005) and 111.4 (P <.0005)
Allopurinol	Control	Quality of dialysis	1528	1634	Patients treated with allopurinol had a significant increase in the quality of dialysis (KT/V) (P: 0.043).
Allopurinol	Control	Creatinine 	1332	1419	There were not significant changes in body mass index, blood urea nitrogen, creatinine,
Allopurinol	Control	Systolic blood pressure 	1127	1331	Overall, after the 12 weeks of allopurinol therapy, systolic and diastolic BP also significantly decreased in allopurinol group, 15.8% (139 to 117, P < 0.0005) and 8.6% (81 to 74, P <.0005), respectively.
Allopurinol	Control	Blood urea nitrogen 	1332	1527	There were not significant changes in body mass index, blood urea nitrogen, creatinine, albumin, cholesterol, triglyceride, hemoglobin, liver enzymes and serum electrolytes level after treatment.
Allopurinol	Control	Uric acid	1006	1126	Uric acid levels decreased significantly during the12 weeks of allopurinol therapy (7.71 ± 1.53 to 5.2 ± 1.2 P < 0.005).
Allopurinol	Control	Diastolic blood pressure 	1127	1331	Overall, after the 12 weeks of allopurinol therapy, systolic and diastolic BP also significantly decreased in allopurinol group, 15.8% (139 to 117, P < 0.0005) and 8.6% (81 to 74, P <.0005), respectively.
Allopurinol	Control	Creatinine 	1332	1527	There were not significant changes in body mass index, blood urea nitrogen, creatinine, albumin, cholesterol, triglyceride, hemoglobin, liver enzymes and serum electrolytes level after treatment.
